-
Nasally Administered Flu Vaccine Comes to United States; Paxil: Not
Recommended for Children; Prilosec Granted OTC Status; Finasteride and
Prostate Cancer; Xolair: First Biologic Agent for Asthma; West Nile
Virus Update; Study Shows COX-2 Inhibitors Appear Safe with Aspirin in
Asthma Patients; Lamictal Approved for Bipolar Disorder
-
Hardy ML. Tai chi: Benefits in older women. Altern Ther Women's Health 2003;5(8):61-62.
-
Keegan L. Chaste tree berry for premenstrual syndrome. Altern Ther Women's Health 2003;5(8):57-61.
-
Black Cohosh May Not Be Safe for Women with Breast Cancer; Viga and Viga for Women Tablets Recalled; Herbal Product Label May Not Accurately Reflect Contents
-
The long-awaited JNC-7 report was recently published in summary form; a more comprehensive manuscript will be forthcoming. JNC-7 takes into account many of the randomized controlled trials dealing with hypertension published over the past few years, and thus, is very much up to date. Some highlights of the report are as follows.
-
Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension; Tazarotene Cream in the Treatment of Psoriasis; Antihyperglycemic Effect of Oolong Tea in Type 2 Diabetes
-
This is the first study to convincingly demonstrate a strong dose-dependent relationship between increasing weight and increasing symptoms of gastroesophageal reflux.
-
Taking into consideration the limitations of this study, it is time to for sliding-scale insulin to join bloodletting and trepanation in the Museum of Medical Anachronisms.
-
While the numbers of cases of West Nile virus infection in the United States were relatively small from 1999 through 2001, in 2002 an epidemiologic explosion occurred with 4156 cases, including 284 deaths, in 44 states plus the District of Columbia.
-
The FDA has approved the first nasally administered flu vaccine. This cold-adapted, temperature sensitive, attenuated, trivalent vaccine is manufactured by MedImmune Vaccine, Inc. and marketed by MedImmune and Wyeth under the name FluMist. The nasal flu vaccine should be available this fall.
